672 results on '"Kung, Andrew L."'
Search Results
2. Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients
3. Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm
4. Author Correction: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
5. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
6. Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
7. Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors
8. Therapeutic targeting of ATR in alveolar rhabdomyosarcoma
9. Antithymocyte globulin exposure in CD34+ T-cell–depleted allogeneic hematopoietic cell transplantation
10. Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation
11. Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy
12. Regulatory T Cell Reconstitution Is Associated with Acute Graft-Versus-Host Disease in Pediatric and Young Adult Hematopoietic Cell Transplant Recipients
13. Predictors for Recent Thymic Emigrant T Cell Reconstitution after Hematopoietic Cell Transplantation
14. Abstract PR01: Identification and pharmacological targeting of treatment-resistant, stem-like breast cancer cells for combination therapy
15. Abstract B023: SMARCAL1 is a novel candidate therapeutic target for ALT-positive osteosarcoma
16. Dynamic network curvature analysis of gene expression reveals novel potential therapeutic targets in sarcoma
17. High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
18. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
19. A Bayesian active learning platform for scalable combination drug screens
20. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
21. BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway
22. Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy
23. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
24. Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma
25. Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations
26. BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
27. BET bromodomain proteins regulate enhancer function during adipogenesis
28. INI1 negative hepatoblastoma, a vanishing entity representing malignant rhabdoid tumor
29. Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy
30. Isabl Platform, a digital biobank for processing multimodal patient data
31. Clonal hematopoiesis in survivors of childhood cancer
32. Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
33. Data from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
34. Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
35. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
36. A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
37. Abstract 849: Evaluation of a transcriptomics-based precision oncology platform for patient-therapy alignment in treatment resistant malignancies
38. Abstract 6541: Geometry of gene expression network reveals potential novel indicator in Ewing sarcoma
39. Abstract 2149: A whole genome sequencing classifier of homologous recombination deficiency
40. Abstract 3142: Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology
41. Supplementary Table S1.4 from Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer
42. Data from Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma
43. Supp. Table 2 from Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma
44. Supplementary Table 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
45. Data Supplement from Antiproliferative Effects of CDK4/6 Inhibition in CDK4-Amplified Human Liposarcoma In Vitro and In Vivo
46. Data from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
47. Supplementary Table 1 from Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion–Driven Cancer
48. Supplementary Figure 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
49. Supplementary Figure 3 from Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer
50. Supplementary Data from Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion–Driven Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.